Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Latest filing published 19 Mar 2026 for Biomarin Pharmaceutical INC, €103k. Read the official filing
Filing timeline
BuySaleBrian Mueller
Insider track record
Disclosed buys
0
Disclosed sells
15
Signal history
Brian Mueller: trading record in brief
All filings by Brian Mueller on record concern Biomarin Pharmaceutical Inc, in the capacity of senior executive. Over a trading history stretching from 28 April 2017 to 17 March 2026, the count stands at 62 filings.
Every open-market trade on record is a sale: 15 sales worth €3.7M. Besides market trades, the filings include 38 share grants and 9 option exercises.
Most recently, on 19 March 2026, the filings show a share grant worth €103k in Biomarin Pharmaceutical Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brian Mueller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations62 total
2,117 shares@ US$56.051.9% of flowCommon StockSEC:0001628280-26-019853:0
9,945 shares@ US$58.519.4% of flowCommon StockSEC:0001628280-26-019008:0
6,683 shares0Common StockSEC:0001628280-26-012529:0
18,497 shares@ US$69.4422.1% of flowCommon StockSEC:0001048477-25-000029:0
11,040 shares0Common StockSEC:0001048477-25-000019:0
588 shares@ US$82.330.8% of flowCommon StockSEC:0001048477-24-000120:0
300 shares@ US$68.6460.4% of flowCommon StockSEC:0001048477-24-000114:0
11,400 shares0Common StockSEC:0001048477-24-000044:0
4,602 shares@ US$88.937.0% of flowCommon StockSEC:0001048477-23-000023:0
9,630 shares0Common StockSEC:0001567619-23-005297:0
12,660 shares0Common StockSEC:0001209191-23-014617:0
2,500 shares@ US$63.102.7% of flowCommon StockSEC:0001567619-23-000965:0
2,500 shares@ US$114.504.9% of flowCommon StockSEC:0001567619-23-000965:1
2,500 shares@ US$63.102.8% of flowCommon StockSEC:0001567619-22-021667:0
2,139 shares@ US$104.504.0% of flowCommon StockSEC:0001567619-22-021363:2
3,761 shares@ US$67.814.5% of flowCommon StockSEC:0001567619-22-021363:3
3,761 shares@ US$104.507.0% of flowCommon StockSEC:0001567619-22-021363:4
2,139 shares@ US$67.812.6% of flowCommon StockSEC:0001567619-22-021363:1
1,101 shares@ US$104.502.0% of flowCommon StockSEC:0001567619-22-021363:0
934 shares@ US$95.091.6% of flowCommon StockSEC:0001567619-22-020937:0
3,500 shares@ US$67.814.3% of flowCommon StockSEC:0001567619-22-015384:0
3,500 shares@ US$94.506.0% of flowCommon StockSEC:0001567619-22-015384:1
7,337 shares@ US$89.5012.0% of flowCommon StockSEC:0001567619-22-013907:0
576 shares@ US$83.920.0004% mcap0.9% of flowCommon StockSEC:0001567619-22-013594:0
340 shares@ US$62.4070.4% of flowCommon StockSEC:0001567619-22-009717:0
25 of 62 declarations
